The US pharmaceutical industry has undergone notable shifts in recent years, influenced by factors such as the COVID-19 ...

In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer discussed what bank industry executives were saying about ...

An international Phase 2 trial will test BMS-986368 as a potentially new oral therapy for managing multiple sclerosis-related ...